Scientists trace a single Pill's journey through the body
NCT ID NCT07314320
Summary
This early-stage study aimed to understand how a new drug called OPC-167832 is processed by the body. Eight healthy male volunteers took a single oral dose containing a tiny, safe amount of radioactive tracer. Researchers then measured how much of the drug was absorbed, how long it stayed in the blood, and how it was eliminated in urine and feces over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion, Inc
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.